Case number 1:24-cv-00336
Bayer Intellectual Property GmbH et al v. Prinston Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 6, 2024 | 13 | STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 6/6/2024 (nms). (Entered: 06/06/2024) (2) |
| Jun 6, 2024 | N/A | SO ORDERED, re (D.I. 13 in 24-cv-336-RGA: D.I. 272 in 21-md-3017-RGA-LDH) STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024. Signed by Judge Richard G. Andrews on 6/6/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 06/06/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Lara FitzSimmons for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney William A. Rakoczy for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Steven J. Birkos for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 14, 2024 | N/A | Pro Hac Vice Attorney Rachel P. Waldron for Prinston Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/14/2024) (0) |
| May 9, 2024 | N/A | SO ORDERED, re (D.I. 10 in 24-cv-336-RGA; D.I. 264 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos, filed by Prinston Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 5/9/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/09/2024) (0) |
| May 8, 2024 | 10 | MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024) (7) |
| May 8, 2024 | 11 | Pro Hac Vice Fee - Credit Card Payment received for William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron, and Steven J. Birkos. ( re 10 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos )( Payment of $ 200, receipt number ADEDC-4402612).(Gattuso, Dominick) (Entered: 05/08/2024) (0) |
| May 8, 2024 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co. Ltd for Prinston Pharmaceutical, Inc. filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024) (2) |
| May 2, 2024 | 9 | STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 5/2/2024 (nms). (Entered: 05/02/2024) (2) |
| May 2, 2024 | N/A | SO ORDERED, re (D.I. 262 in 21-md-3017-RGA-LDH; D.I. 9 in 24-cv-336-RGA) STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024. Signed by Judge Richard G. Andrews on 5/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/02/2024) (0) |
| Mar 20, 2024 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 03/20/2024) (0) |
| Mar 19, 2024 | 8 | WAIVER OF SERVICE returned executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG: For Prinston Pharmaceutical, Inc. waiver sent on 3/15/2024, answer due 5/14/2024. (Fahnestock, Derek) (Entered: 03/19/2024) (1) |
| Mar 14, 2024 | 1 | COMPLAINT filed against Prinston Pharmaceutical, Inc. ( Filing fee $ 405, receipt number ADEDC-4361997.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(apk) (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 03/14/2024) (3) |
| Mar 14, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/2/2024. Date of Expiration of Patent: N/A.Thirty Month Stay Deadline: 8/2/2026. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH, Bayer Pharma AG filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (apk) (Entered: 03/14/2024) (1) |
| Mar 14, 2024 | 7 | Summons Issued as to Prinston Pharmaceutical, Inc. on 3/14/2024. (apk) (Entered: 03/14/2024) (2) |
| Mar 14, 2024 | N/A | Remark: MDL Panel has been Advised (apk) (Entered: 03/14/2024) (0) |
